According to AMR’s prediction, The Renal Denervation Market was valued at USD 156,327.4 thousand in 2020 and is expected to reach USD 4,555,983.0 thousand by 2030, growing at a CAGR of 40.7% from 2021 to 2030. Renal Denervation is a type of heart attack. non-stop. As a result of the problem, the ventricles receive insufficient blood. Blood can clot and block the atria at the same time. These clots can enter the circulation and reach the brain, causing a stroke. During renal failure, the upper and lower chambers of the heart beat constantly, without disturbance, and without coordination, which can cause shortness of breath, chest pain, weakness, headache, and is a disappointment.

♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:

Key Findings of the Study –

  • From the end user, the hospital sector recorded the highest income in 2020.
  • It is expected that Europe will register the highest growth rate in the coming years.
  • The major players of the Renal Denervation market are profiled in this report and their strategies are carefully analyzed which helps to understand the competitive outlook of the Renal Denervation industry.

The renal denervation market is expected to witness significant growth in the near future. The renal denervation market has attracted interest from the medical and healthcare sector due to the increase in hypertension worldwide. In addition, the acquisition of alternative and better technologies for equipment-saving systems, such as micro-perfusion, and the expansion of medical equipment in emerging countries are expected to drive market growth. For example, Mercator MedSystem’s denervation technology is based on low infusion. It delivers chemicals to one area to damage the renal arteries, which helps lower the patient’s blood pressure.

Various market players have developed strategies to expand its business and strengthen its position in the market. For example, in 2019 Abbott Laboratories, a manufacturer of medical devices and technology, acquired St. Jude Medical to provide a renal denervation system for the treatment of hypertension. It provides EnligHTN renal denervation, which allows the latest efficiency in the treatment of high blood pressure. It also reduces systolic blood pressure in the patient. Due to this, the major players have acquired other companies to provide kidney denervation system which increases the growth of the market.

♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:

The denervation system of the kidney works through different technologies such as ultrasound, radiofrequency and micro-infusion. Radiofrequency renal ablation is an effective method of controlling drug-resistant hypertension. One method is enough to lower blood pressure for two years. Radiofrequency renal ablation is a catheter-based procedure that involves inserting a catheter into the renal artery through the femoral artery. A catheter uses several electrodes to deliver radio waves. This energy is used to destroy the nerves by creating a series of ablations through the kidney nerves.

Key Market Players –

Major key players that operate in the industry are Ablative Solutions, Inc, Abbott Laboratories, Johnson & Johnson, Cardiosonic Ltd, Boston Scientific Corporation, Medtronic plc, Mercator MedSystems, Inc, ReCor Medical, Inc, Renal Dynamics Limited, terumo corporation

By Region –

North America
(U.S., Canada, Mexico)

Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)

♦ 𝐕𝐢𝐬𝐢𝐭 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:

Frequently Asked Questions?

Q1. What is the total market value of global renal denervation market?

Q2. Which market holds the maximum market share of the global renal denervation market?

Q3. What will be global renal denervation market growth in 2030?

Q4. What are the key trends in the global renal denervation market?

Q5. What are the key growth strategies of global renal denervation market players?

Q6. How the company profile has been selected?

About Us –

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Leave a comment

Your email address will not be published. Required fields are marked *